Literature DB >> 2128496

Kinetic evaluation of MAO-B-activity following oral administration of selegiline and desmethyl-selegiline in the rat.

H O Borbe1, G Niebch, B Nickel.   

Abstract

The monoamine oxidase (MAO) B activity of rat brain was inhibited by selegiline and its desmethyl-metabolite in vitro with IC50-values of 11.25 nmol/l and 625.00 nmol/l, respectively. When measured in an ex vivo experiment following oral treatment of rats, the large difference in potency was distinctly reduced, from factor 60 in vitro to factor 3 ex vivo. Restoration experiments of MAO-B-activity after cessation of treatment revealed a nearly identical time course for both compounds. It is concluded that desmethyl-selegiline is an irreversible blocker of MAO-B, nearly equipotent to selegiline after multiple oral administration. No pharmacologically relevant inhibition of MAO-A was found with both compounds.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2128496     DOI: 10.1007/978-3-7091-9113-2_18

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  5 in total

1.  Pressor response to oral tyramine and monoamine oxidase inhibition during treatment with ralfinamide (NW-1029).

Authors:  Andrea F D Di Stefano; Milko Massimiliano Radicioni; Antonio Rusca
Journal:  Neurotox Res       Date:  2012-08-08       Impact factor: 3.911

2.  Dose linearity study of selegiline pharmacokinetics after oral administration: evidence for strong drug interaction with female sex steroids.

Authors:  K Laine; M Anttila; A Helminen; H Karnani; R Huupponen
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

3.  Pressor response to oral tyramine during co-administration with safinamide in healthy volunteers.

Authors:  Andrea Francesco Daniele Di Stefano; Antonio Rusca
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-08-19       Impact factor: 3.000

Review 4.  Clinical pharmacokinetics and pharmacodynamics of selegiline. An update.

Authors:  I Mahmood
Journal:  Clin Pharmacokinet       Date:  1997-08       Impact factor: 6.447

5.  Lack of evidence for neonatal misoprostol neurodevelopmental toxicity in C57BL6/J mice.

Authors:  Claire M Koenig; Cheryl K Walker; Lihong Qi; Isaac N Pessah; Robert F Berman
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.